135 related articles for article (PubMed ID: 3149087)
1. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
[TBL] [Abstract][Full Text] [Related]
3. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
Bandilla K; Missler B; Klein-Reesink B
Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777
[TBL] [Abstract][Full Text] [Related]
4. [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
Sakurai T; Iso T; Inoue H; Sano K; Takeuchi K; Takagishi K
Ryumachi; 2001 Jun; 41(3):635-45. PubMed ID: 11505513
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
[TBL] [Abstract][Full Text] [Related]
6. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis.
Dequeker J; Gevers G
Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing experience with auranofin in the Federal Republic of Germany.
Schattenkirchner M; Missler B; Mulz D
Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
Vlak T; Stambuk B
Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
[TBL] [Abstract][Full Text] [Related]
9. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
[TBL] [Abstract][Full Text] [Related]
10. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of auranofin: results of a randomized clinical trial.
Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of auranofin: a review of clinical experience.
Blodgett RC; Pietrusko RG
Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
[TBL] [Abstract][Full Text] [Related]
14. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
15. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
[TBL] [Abstract][Full Text] [Related]
16. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
[TBL] [Abstract][Full Text] [Related]
17. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of chronic polyarthritis with low-dose methotrexate].
Karger T; Rau R
Dtsch Med Wochenschr; 1988 May; 113(21):839-46. PubMed ID: 3371211
[TBL] [Abstract][Full Text] [Related]
19. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
Atakhodzhaeva ZA; Sigidin IaA
Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
[TBL] [Abstract][Full Text] [Related]
20. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
